An egg-protein hydrolysate (NWT-03) to boost brain function - mind your blood vessels

An egg-protein hydrolysate (NWT-03) to boost brain function - mind your blood vessels - An egg-protein hydrolysate and brain function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON50991

Enrollment

Registered

2021-01-19

Start date

2021-05-26

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance Syndrome Metabolic Syndrome Syndrome X

Interventions

During the study, subjects will receive daily (in the morning) 5.7 g NWT*03 or placebo powders for 36 weeks.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Men and women, aged between 60-75 years - Subjective cognitive decline (SCD) - BMI between 25-35 kg/m2 - Fasting plasma glucose

Exclusion criteria

Exclusion criteria: - Left-handedness - Current smoker, or smoking cessation

Design outcomes

Primary

Measure	Time frame
The primary endpoints are the difference in brain vascular function and cognitive performance between interventions.	—

Secondary

Measure	Time frame
Secondary endpoints are effects on insulin-sensitivity and peripheral vascular function.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)